Cargando…

Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−) Kupffer Cell Subsets

BACKGROUND: Lipopolysaccharide (LPS) decreases hepatic CETP (cholesteryl ester transfer protein) expression albeit that the underlying mechanism is disputed. We recently showed that plasma CETP is mainly derived from Kupffer cells (KCs). In this study, we investigated the role of KC subsets in the m...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Tuin, Sam J. L., Li, Zhuang, Berbée, Jimmy F. P., Verkouter, Inge, Ringnalda, Linda E., Neele, Annette E., van Klinken, Jan B., Rensen, Sander S., Fu, Jingyuan, de Winther, Menno P. J., Groen, Albert K., Rensen, Patrick C. N., Willems van Dijk, Ko, Wang, Yanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907564/
https://www.ncbi.nlm.nih.gov/pubmed/29525783
http://dx.doi.org/10.1161/JAHA.117.008105
_version_ 1783315556077666304
author van der Tuin, Sam J. L.
Li, Zhuang
Berbée, Jimmy F. P.
Verkouter, Inge
Ringnalda, Linda E.
Neele, Annette E.
van Klinken, Jan B.
Rensen, Sander S.
Fu, Jingyuan
de Winther, Menno P. J.
Groen, Albert K.
Rensen, Patrick C. N.
Willems van Dijk, Ko
Wang, Yanan
author_facet van der Tuin, Sam J. L.
Li, Zhuang
Berbée, Jimmy F. P.
Verkouter, Inge
Ringnalda, Linda E.
Neele, Annette E.
van Klinken, Jan B.
Rensen, Sander S.
Fu, Jingyuan
de Winther, Menno P. J.
Groen, Albert K.
Rensen, Patrick C. N.
Willems van Dijk, Ko
Wang, Yanan
author_sort van der Tuin, Sam J. L.
collection PubMed
description BACKGROUND: Lipopolysaccharide (LPS) decreases hepatic CETP (cholesteryl ester transfer protein) expression albeit that the underlying mechanism is disputed. We recently showed that plasma CETP is mainly derived from Kupffer cells (KCs). In this study, we investigated the role of KC subsets in the mechanism by which LPS reduces CETP expression. METHODS AND RESULTS: In CETP‐transgenic mice, LPS markedly decreased hepatic CETP expression and plasma CETP concentration without affecting hepatic macrophage number. This was paralleled by decreased expression of the resting KC markers C‐type lectin domain family 4, member f (Clec4f) and V‐set and immunoglobulin domain containing 4 (Vsig4), while expression of the infiltrating monocyte marker lymphocyte antigen 6 complex locus C (Ly6C) was increased. Simultaneously, the ratio of plasma high‐density lipoprotein‐cholesterol over non–high‐density lipoprotein‐cholesterol transiently increased. After ablation hepatic macrophages via injection with liposomal clodronate, the reappearance of hepatic gene and protein expression of CETP coincided with Clec4f and Vsig4, but not Ly6C. Double‐immunofluorescence staining showed that CETP co‐localized with Clec4f(+) KCs and not Ly6C(+) monocytes. In humans, microarray gene‐expression analysis of liver biopsies revealed that hepatic expression and plasma level of CETP both correlated with hepatic VSIG4 expression. LPS administration decreased the plasma CETP concentration in humans. In vitro experiments showed that LPS reduced liver X receptor‐mediated CETP expression. CONCLUSIONS: Hepatic expression of CETP is exclusively confined to the resting KC subset (ie, F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−)). LPS activated resting KCs, leading to reduction of Clec4f and Vsig4 expression and reduction of hepatic CETP expression, consequently decreasing plasma CETP and raising high‐density lipoprotein (HDL)‐cholesterol. This sequence of events is consistent with the anti‐inflammatory role of HDL in the response to LPS and may be relevant as a defense mechanism against bacterial infections.
format Online
Article
Text
id pubmed-5907564
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-59075642018-05-01 Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−) Kupffer Cell Subsets van der Tuin, Sam J. L. Li, Zhuang Berbée, Jimmy F. P. Verkouter, Inge Ringnalda, Linda E. Neele, Annette E. van Klinken, Jan B. Rensen, Sander S. Fu, Jingyuan de Winther, Menno P. J. Groen, Albert K. Rensen, Patrick C. N. Willems van Dijk, Ko Wang, Yanan J Am Heart Assoc Original Research BACKGROUND: Lipopolysaccharide (LPS) decreases hepatic CETP (cholesteryl ester transfer protein) expression albeit that the underlying mechanism is disputed. We recently showed that plasma CETP is mainly derived from Kupffer cells (KCs). In this study, we investigated the role of KC subsets in the mechanism by which LPS reduces CETP expression. METHODS AND RESULTS: In CETP‐transgenic mice, LPS markedly decreased hepatic CETP expression and plasma CETP concentration without affecting hepatic macrophage number. This was paralleled by decreased expression of the resting KC markers C‐type lectin domain family 4, member f (Clec4f) and V‐set and immunoglobulin domain containing 4 (Vsig4), while expression of the infiltrating monocyte marker lymphocyte antigen 6 complex locus C (Ly6C) was increased. Simultaneously, the ratio of plasma high‐density lipoprotein‐cholesterol over non–high‐density lipoprotein‐cholesterol transiently increased. After ablation hepatic macrophages via injection with liposomal clodronate, the reappearance of hepatic gene and protein expression of CETP coincided with Clec4f and Vsig4, but not Ly6C. Double‐immunofluorescence staining showed that CETP co‐localized with Clec4f(+) KCs and not Ly6C(+) monocytes. In humans, microarray gene‐expression analysis of liver biopsies revealed that hepatic expression and plasma level of CETP both correlated with hepatic VSIG4 expression. LPS administration decreased the plasma CETP concentration in humans. In vitro experiments showed that LPS reduced liver X receptor‐mediated CETP expression. CONCLUSIONS: Hepatic expression of CETP is exclusively confined to the resting KC subset (ie, F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−)). LPS activated resting KCs, leading to reduction of Clec4f and Vsig4 expression and reduction of hepatic CETP expression, consequently decreasing plasma CETP and raising high‐density lipoprotein (HDL)‐cholesterol. This sequence of events is consistent with the anti‐inflammatory role of HDL in the response to LPS and may be relevant as a defense mechanism against bacterial infections. John Wiley and Sons Inc. 2018-03-10 /pmc/articles/PMC5907564/ /pubmed/29525783 http://dx.doi.org/10.1161/JAHA.117.008105 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
van der Tuin, Sam J. L.
Li, Zhuang
Berbée, Jimmy F. P.
Verkouter, Inge
Ringnalda, Linda E.
Neele, Annette E.
van Klinken, Jan B.
Rensen, Sander S.
Fu, Jingyuan
de Winther, Menno P. J.
Groen, Albert K.
Rensen, Patrick C. N.
Willems van Dijk, Ko
Wang, Yanan
Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−) Kupffer Cell Subsets
title Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−) Kupffer Cell Subsets
title_full Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−) Kupffer Cell Subsets
title_fullStr Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−) Kupffer Cell Subsets
title_full_unstemmed Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−) Kupffer Cell Subsets
title_short Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(−) Kupffer Cell Subsets
title_sort lipopolysaccharide lowers cholesteryl ester transfer protein by activating f4/80(+)clec4f(+)vsig4(+)ly6c(−) kupffer cell subsets
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907564/
https://www.ncbi.nlm.nih.gov/pubmed/29525783
http://dx.doi.org/10.1161/JAHA.117.008105
work_keys_str_mv AT vandertuinsamjl lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT lizhuang lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT berbeejimmyfp lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT verkouteringe lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT ringnaldalindae lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT neeleannettee lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT vanklinkenjanb lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT rensensanders lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT fujingyuan lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT dewinthermennopj lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT groenalbertk lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT rensenpatrickcn lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT willemsvandijkko lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets
AT wangyanan lipopolysaccharidelowerscholesterylestertransferproteinbyactivatingf480clec4fvsig4ly6ckupffercellsubsets